The 9th KOL Summit

9 KOL Thought Leadership

It is imperative for life science organizations to differentiate themselves from their competitors in the marketplace while aligning company objectives across their internal organization. Effectively communicating the benefits of a product to KOLs and external stakeholders is an integral part of maximizing the commercial potential of a product. Therefore, it is important to plan and develop an approach to identify relevant and effective KOLs, understand their needs and interests, and the audiences to create a sustainable and valuable relationship for both parties.

As the healthcare landscape continues to shift from opinion-based to evidence-based medicine, it is essential for pharmaceutical and medical device companies to develop best practices to build a strong brand strategy that aligns with an organization’s objectives, while also delivering patient-centric outcomes.

The 9th KOL Thought Leadership and Engagement Summit will provide attendees with valuable insights that engage traditional and non-traditional KOLs, and discuss the priorities and motivating factors for patient groups, payers and managed care organizations. Join our esteemed faculty as they share disruptive techniques for attracting external stakeholders in meaningful ways and discuss strategies for commercial and medical groups to work together while maintaining compliance and delivering patient-centric outcomes.